GKV Capital Management’s Eli Lilly LLY Stock Holding History

GKV Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16.2M	Buy	13,969 +43	+0.3%	+$50.7K	5.2%	3
2026 Q2	$16.7M	Buy	13,926 +34	+0.2%	+$34.7K	5.39%	3
2026 Q1	$12.8M	Sell	13,892 -679	-5%	-$688K	4.79%	3
2025 Q4	$15.7M	Sell	14,571 -160	-1%	-$153K	5.86%	3
2025 Q3	$11.2M	Sell	14,731 -198	-1%	-$147K	4.44%	4
2025 Q2	$11.6M	Sell	14,929 -25	-0.2%	-$19.4K	5.15%	4
2025 Q1	$12.4M	Sell	14,954 -508	-3%	-$423K	6.14%	2
2024 Q4	$11.9M	Buy	+15,462	New	+$12.8M	4.87%	4

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

GKV Capital Management's LLY Position: Q3 2026 in Review

GKV Capital Management increased its Eli Lilly (LLY) stake by 0.31% in Q3 2026, buying an estimated $50.7K and bringing the position to 13,969 shares worth $16.2M. The position accounts for 5.2% of the portfolio, ranked #3.

GKV Capital Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $16.7M in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

GKV Capital Management held 13,969 shares of Eli Lilly worth $16.2M as of Q3 2026.
GKV Capital Management bought 43 Eli Lilly shares in Q3 2026, an estimated $50.7K.
Eli Lilly made up 5.2% of GKV Capital Management's portfolio in Q3 2026, its #3 holding.
GKV Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
GKV Capital Management's Eli Lilly position peaked at $16.7M in Q2 2026.
3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on GKV Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.